blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3290418

EP3290418 - JANUS KINASE (JAK) INHIBITORS [Right-click to bookmark this link]
Former [2018/10]JAK INHIBITORS
[2019/11]
StatusNo opposition filed within time limit
Status updated on  20.03.2020
Database last updated on 24.08.2024
FormerThe patent has been granted
Status updated on  12.04.2019
FormerGrant of patent is intended
Status updated on  27.02.2019
FormerRequest for examination was made
Status updated on  02.02.2018
FormerThe international publication has been made
Status updated on  04.11.2016
Most recent event   Tooltip08.07.2022Lapse of the patent in a contracting state
New state(s): IS, MK		published on 10.08.2022  [2022/32]
Applicant(s)For all designated states
Wuxi Fortune Pharmaceutical Co., Ltd
No.2 Rongyang 1st Road
Xishan Economic Zone
Wuxi, Jiangsu 214191 / CN
[2018/10]
Inventor(s)01 / WU, Hao
No. 2 Rongyang 1st Road
Xishan Economic Zone
Wuxi, Jiangsu 214191 / CN
02 / LI, Peng
No. 2 Rongyang 1st Road
Xishan Economic Zone
Wuxi, Jiangsu 214191 / CN
03 / MAO, Weiwei
No. 2 Rongyang 1st Road
Xishan Economic Zone
Wuxi, Jiangsu 214191 / CN
04 / CHEN, Shuhui
No. 2 Rongyang 1st Road
Xishan Economic Zone
Wuxi, Jiangsu 214191 / CN
05 / WANG, Fei
No. 2 Rongyang 1st Road
Xishan Economic Zone
Wuxi, Jiangsu 214191 / CN
06 / LI, Jian
No. 2 Rongyang 1st Road
Xishan Economic Zone
Wuxi, Jiangsu 214191 / CN
 [2019/20]
Former [2018/10]01 / WU, Hao
288 Futezhong Road
Pudong New Area
Shanghai 200131 / CN
02 / LI, Peng
288 Futezhong Road
Pudong New Area
Shanghai 200131 / CN
03 / MAO, Weiwei
288 Futezhong Road
Pudong New Area
Shanghai 200131 / CN
04 / CHEN, Shuhui
288 Futezhong Road
Pudong New Area
Shanghai 200131 / CN
05 / WANG, Fei
288 Futezhong Road
Pudong New Area
Shanxi 200131 / CN
06 / LI, Jian
288 Futezhong Road
Pudong New Area
Shanghai 200131 / CN
Representative(s)Cabinet Laurent & Charras
Le Contemporain
50 Chemin de la Bruyère
69574 Dardilly Cedex / FR
[N/P]
Former [2018/10]Ferreccio, Rinaldo
Botti & Ferrari S.r.l. Via Cappellini, 11
20124 Milano / IT
Application number, filing date16785915.626.04.2016
[2018/10]
WO2016CN80208
Priority number, dateCN20151021318729.04.2015         Original published format: CN201510213187
[2018/10]
Filing languageZH
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016173484
Date:03.11.2016
Language:ZH
[2016/44]
Type: A1 Application with search report 
No.:EP3290418
Date:07.03.2018
Language:EN
[2018/10]
Type: B1 Patent specification 
No.:EP3290418
Date:15.05.2019
Language:EN
[2019/20]
Search report(s)International search report - published on:CN03.11.2016
(Supplementary) European search report - dispatched on:EP14.09.2018
ClassificationIPC:C07D471/04, C07D487/04, C07D417/14, C07D413/14, A61K31/437, A61K31/519, A61K31/428, A61K31/423, A61K31/4985, A61K31/506, A61P37/00
[2018/10]
CPC:
C07D487/04 (EP,KR,US); C07D471/04 (EP,KR,US); A61K31/437 (EP,KR,US);
A61K31/519 (EP,KR,US); A61P19/00 (EP); A61P29/00 (EP);
A61P35/00 (EP); A61P37/00 (EP); A61P37/02 (EP);
A61P37/06 (EP); A61P43/00 (EP); C07D413/14 (EP,KR,US);
C07D417/14 (EP,KR,US); A61K31/423 (EP,US); A61K31/428 (EP,US);
A61K31/4985 (EP,US); A61K31/506 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/10]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:JANUS KINASE (JAK)-HEMMSTOFFE[2019/11]
English:JANUS KINASE (JAK) INHIBITORS[2019/11]
French:INHIBITEURS DE JANUS KINASE (JAK)[2019/11]
Former [2018/10]JAK-HEMMER
Former [2018/10]JAK INHIBITORS
Former [2018/10]INHIBITEURS DE JAK
Entry into regional phase25.09.2017Translation filed 
25.09.2017National basic fee paid 
25.09.2017Search fee paid 
25.09.2017Designation fee(s) paid 
25.09.2017Examination fee paid 
Examination procedure25.09.2017Examination requested  [2018/10]
25.09.2017Date on which the examining division has become responsible
28.02.2019Communication of intention to grant the patent
04.04.2019Fee for grant paid
04.04.2019Fee for publishing/printing paid
04.04.2019Receipt of the translation of the claim(s)
Opposition(s)18.02.2020No opposition filed within time limit [2020/17]
Fees paidRenewal fee
28.03.2018Renewal fee patent year 03
26.03.2019Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL15.05.2019
CY15.05.2019
EE15.05.2019
HR15.05.2019
LT15.05.2019
LV15.05.2019
MC15.05.2019
MK15.05.2019
MT15.05.2019
RS15.05.2019
SI15.05.2019
SK15.05.2019
SM15.05.2019
BG15.08.2019
IS15.09.2019
[2022/31]
Former [2022/28]AL15.05.2019
CY15.05.2019
EE15.05.2019
HR15.05.2019
LT15.05.2019
LV15.05.2019
MC15.05.2019
MT15.05.2019
RS15.05.2019
SI15.05.2019
SK15.05.2019
SM15.05.2019
BG15.08.2019
Former [2020/52]AL15.05.2019
EE15.05.2019
HR15.05.2019
LT15.05.2019
LV15.05.2019
MC15.05.2019
RS15.05.2019
SI15.05.2019
SK15.05.2019
SM15.05.2019
BG15.08.2019
Former [2020/26]AL15.05.2019
EE15.05.2019
HR15.05.2019
LT15.05.2019
LV15.05.2019
RS15.05.2019
SI15.05.2019
SK15.05.2019
SM15.05.2019
BG15.08.2019
Former [2020/14]AL15.05.2019
EE15.05.2019
HR15.05.2019
LT15.05.2019
LV15.05.2019
RS15.05.2019
SK15.05.2019
SM15.05.2019
BG15.08.2019
Former [2020/11]AL15.05.2019
EE15.05.2019
HR15.05.2019
LT15.05.2019
LV15.05.2019
RS15.05.2019
SK15.05.2019
BG15.08.2019
Former [2019/52]AL15.05.2019
HR15.05.2019
LT15.05.2019
LV15.05.2019
RS15.05.2019
BG15.08.2019
Former [2019/50]AL15.05.2019
HR15.05.2019
LT15.05.2019
LV15.05.2019
RS15.05.2019
Former [2019/47]LT15.05.2019
Documents cited:Search[A]WO2011130146  (ARRAY BIOPHARMA INC [US], et al) [A] 1-9 * claim 1 *;
 [A]WO2012177606  (INCYTE CORP [US], et al) [A] 1-9 * claim 1 *;
 [A]WO2013055645  (ARRAY BIOPHARMA INC [US], et al) [A] 1-9* claim 1 *
International search[A]CN102985424  (ARRAY BIOPHARMA INC) [A] 1-9 * , the whole document *;
 [A]CN103987713  (ARRAY BIOPHARMA INC) [A] 1-9* , the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.